Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | HyperHep B |
| Active Ingredient: | Hepatitis B immunoglobulin, human 220IU/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pharmaco (NZ) Limited |
| Manufacturer: | Grifols Therapeutics LLC, North Carolina, United States of America |
Dated this 27th day of July 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).